Penghambat Siklooksigenase-2: Obat Analgesik Anti-inflamasi Nonsteroid (Ains) Masa Depan
DOI:
https://doi.org/10.18196/mmjkk.v2i1.1504Keywords:
NSAIDs, COX, PG, Side effect, Obat AINS, Efek sampingAbstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) exert its action through inhibition of prostaglandin (PG) synthesis. These drugs act by inhibition of cyclooxygenase (COX) which involved in PG synthesis. COX-lwhich is involv in PG synthesis may maintains normal gastric mucosa and influences kidney function. COX-2 a COX-1 homolog which is induced by inflammatory stimulan is inhibited by NSAIDs. The anti-inflammatory actions of NSAIDs are due to the inhibition of COX-2, whereas the unwanted side effects such as irritation of the stomach lining and toxic effect on the kidney are due to inhibition of the COX-1. In the treatment of inflammatory diseases such as osteoarthritis, using NSAIDs with selective COX-2 inhibition show effective benefit with minimal gastrointestinal side effect.
Obat analgesik anti-inflamasi nonsteroid (AINS) bekerja menghambat enzim cyclooxygenase (COX) sehingga sintesis prostaglandin (PG) juga terhambat. COX- 1 yang terlibat dalam sintesis PG dapat mempengaruhi fungsi ginjal dan pertahanan mukosa lambung, sehingga hambatan pada COX-1 oleh obat AINS dapa: menyebabkan timbulnya efek samping pada lambung dan ginjal. COX-2 suatu ho¬molog COX-1 terinduksi pada keadaan inflamasi dapat dihambat oleh obat AINS. Oleh karena itu obat AINS yang selektif menghambat COX-2 akan lebih menguntungkan terapi penyakit inflamasi seperti osteoartritis karena efek samping pada saluran cerna dan ginjal dapat dicegah.
References
Anonim, (1999), Aspirin and Tylenol as Enzyme Inhibitors, (http://pharmacy.drake.edu/faculty/ Lhenderson/Unitl/.Aspirin TylenolEicSyn. html).
Gotlieb, D., (1999), COX 1 and 2: The cyclooxygenase systems, (http://www.arthritis.co.za/cox.html).
Kalim, H., & Handono, K., (2000), Masalah Penyakit Rematik di Indonesia serta Upaya-Upaya Penanggulangannya, Konas IKAFI, Malang.
Neal,MJ., (1997), Non-steroidal anti-inflammatory drugs (NSAIDs) in Medical Pharmacology at a Glance, Blackwell Science Ltd.
Setiabudy,R., (2000), Penggunaan Rasional Obat Anti-inflamasi Nonsteroid, Majalah Farmakologi dan Terapi Indonesia 13 (1): 29-33.
Vane, SJR., (1999) Selective COX-2 inhibition A way forward for NS AID development, (http:// www.rheumaclub.com/COX2/SelCOX2. htm).
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.